Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study

American Journal of Psychiatry

Volumn 160, Issue 1, 2003, Pages 167-169

  Zanarini, Mary C ^a   Frankenburg, Frances R ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; AGGRESSION; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGGRESSION; BORDERLINE PERSONALITY DISORDER; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0037225853     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.1.167     Document Type: Article

References (9)

1. American Psychiatric Association: Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001; 158(Oct suppl)
2. Hibbeln JR, Salem N: Omega-3 fatty acids and psychiatric disorders: Current status of the field, in Fatty Acids: Physiological and Behavioral Functions. Edited by Mostofsky D, Yehuda S, Salem N. Totowa, NJ, Humana Press, 2001, pp 311-330
3. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56:407-412
4. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159:477-479
5. Zanarini MC, Frankenburg FR, Chauncey DL, Gunderson JG: The Diagnostic Interview for Personality Disorders: Interrater and test-retest reliability. Compr Psychiatry 1987; 28:467-480
6. Spitzer RL, Williams JBW, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R (SCID), I: History, rationale, and description. Arch Gen Psychiatry 1992; 49:624-629
7. Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL: The Revised Diagnostic Interview for Borderlines: Discriminating BPD from other axis II disorders. J Personal Disord 1989; 3: 10-18
8. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, Herbert JL, Bernstein DP: Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991; 3(suppl):S44-51
9. Montgomery SA, Åsberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389